McKesson (NYSE:MCK) stock dropped 12.1% after the drug distributor's first-quarter revenue came short of Wall Street estimates. The company also upped its adjusted earnings per diluted share guidance ...
Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. The equity ...
Baird downgraded medical distributor McKesson (NYSE:MCK) to neutral from outperform on Tuesday, calling the company's plans to conduct an investor event with the sell-side community "unusual." "The ...
In the latest trading session, McKesson (MCK) closed at $652.83, marking a -1.38% move from the previous day. The stock's change was more than the S&P 500's daily loss of 1.57%. At the same time, the ...
Fintel reports that on November 10, 2025, Wells Fargo maintained coverage of McKesson (NYSE:MCK) with a Equal-Weight recommendation. As of November 9, 2025, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results